Newsfeeds - Spark Newswire

1 minute read

Quest Diagnostics Q4 Adjusted EPS $1.98 Beats $1.91 Estimate, Sales $2.33B Beat $2.26B Estimate

Today, 9:52 AM

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $1.98 per share which beat the analyst consensus estimate of $1.91 by 3.66 percent. This is a 40.54 percent decrease over earnings of $3.33 per share from the

DGX

2 minute read

Analyst Ratings

5 Analysts Have This to Say About Quest Diagnostics

By Benzinga Insights

Today, 9:52 AM

Over the past 3 months, 5 analysts have published their opinion on Quest Diagnostics (NYSE:DGX) stock. These analysts…

DGX

1 minute read

Evercore ISI Group Initiates Coverage On Quest Diagnostics with In-Line Rating, Announces Price Target of $159

By Benzinga Newsdesk

Today, 9:52 AM

Evercore ISI Group analyst Elizabeth Anderson initiates coverage on Quest Diagnostics (NYSE:DGX) with a In-Line rating and announces Price Target of $159.

DGX

1 minute read

Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $154

By Benzinga Newsdesk

Today, 9:52 AM

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $143 to $154.

DGX

1 minute read

Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $158

By Benzinga Newsdesk

Today, 9:52 AM

Morgan Stanley analyst Ricky Goldwasser maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $146 to $158.

DGX

1 minute read

These 2 Defensive Plays Are Highlights Of CNBC’s ‘Final Trades’

By Priya Nigam

Today, 9:52 AM

On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5%

DGX

5 minute read

‘New Alzheimer’s Blood Tests May Be Game-Changers For Treating The Disease’ – Bloomberg

By Benzinga Newsdesk

Today, 9:52 AM

https://www.mercurynews.com/2022/12/19/new-alzheimers-blood-tests-may-be-game-changers-for-treating-the-disease/ There’s no simple way to tell who has Alzheimer’s disease, but with a blockbuster treatment

DGX

1 minute read

Analyst Ratings

Where Quest Diagnostics Stands With Analysts

By Benzinga Insights

Today, 9:52 AM

Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent…

DGX

4 minute read

Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights

Today, 9:52 AM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

BDX

2 minute read

News

Quest Diagnostics Awarded Laboratory Stewardship Platform And Services Agreement With Premier, Inc.

By Benzinga Newsdesk

Today, 9:52 AM

Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, has been awarded a group purchasing agreement for its laboratory stewardship solution with Premier Inc.

DGX